- Home
- SORA vs ITOS Comparison
SORA vs ITOS Comparison
Compare SORA & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SORA
- ITOS
- Stock Information
- Founded
- SORA 2001
- ITOS 2011
- Country
- SORA Hong Kong
- ITOS United States
- Employees
- SORA N/A
- ITOS N/A
- Industry
- SORA Other Specialty Stores
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SORA Industrials
- ITOS Health Care
- Exchange
- SORA Nasdaq
- ITOS Nasdaq
- Market Cap
- SORA 231.5M
- ITOS 270.7M
- IPO Year
- SORA 2025
- ITOS 2020
- Fundamental
- Price
- SORA N/A
- ITOS $10.10
- Analyst Decision
- SORA
- ITOS Hold
- Analyst Count
- SORA 0
- ITOS 6
- Target Price
- SORA N/A
- ITOS $10.60
- AVG Volume (30 Days)
- SORA 297.5K
- ITOS 2.7M
- Earning Date
- SORA 01-01-0001
- ITOS 04-28-2025
- Dividend Yield
- SORA N/A
- ITOS N/A
- EPS Growth
- SORA N/A
- ITOS N/A
- EPS
- SORA N/A
- ITOS N/A
- Revenue
- SORA $17,619,363.00
- ITOS $35,000,000.00
- Revenue This Year
- SORA N/A
- ITOS N/A
- Revenue Next Year
- SORA N/A
- ITOS $31.74
- P/E Ratio
- SORA N/A
- ITOS N/A
- Revenue Growth
- SORA N/A
- ITOS 177.89
- 52 Week Low
- SORA $6.34
- ITOS $4.80
- 52 Week High
- SORA $14.15
- ITOS $18.13
- Technical
- Relative Strength Index (RSI)
- SORA N/A
- ITOS 74.18
- Support Level
- SORA N/A
- ITOS $9.85
- Resistance Level
- SORA N/A
- ITOS $11.35
- Average True Range (ATR)
- SORA 0.00
- ITOS 0.49
- MACD
- SORA 0.00
- ITOS 0.19
- Stochastic Oscillator
- SORA 0.00
- ITOS 69.02
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.